Article
The Cutaneous Lymphoma Foundation has launched a research awards program aimed at funding innovative research for the disease.
The Cutaneous Lymphoma Foundation has launched a research awards program aimed at funding innovative research for the disease.
The CLARIONS program - Curing Cutaneous Lymphoma by Advancing Research, Innovation and Offering New Solutions - supports investigators who will conduct innovative cutaneous lymphoma research, with a goal of discovering new and improved therapies for the disease.
The program will help to fund research particularly in the areas of etiology and risk factors of the disease; measures of disease impact on individuals and populations affected by cutaneous lymphoma; optimizing therapies for the disease; and improving quality of life for those who suffer from cutaneous lymphoma.
The application deadline is July 31. Recipients will be notified in November, and grants will be awarded at the American Society of Hematology meeting in December.